M1317 – Patients who are counseled on connection with a csp and explicitly opt out

Long description

Patients who are counseled on connection with a csp and explicitly opt out

Short description

Pts counsl cpt opt out

Pricing indicator

00 Not separately priced by Part B (bundled, not covered or Part A only)

Medicare coverage

C Carrier judgment – coverage decided by the Medicare contractor

BETOS category

Z2 Undefined codes

Added

January 1, 2024

Last change

January 1, 2024 – No change

Nearby M codes

• M1309 – Palliative care services provided to patient any time during the measurement period
• M1310 – Patient screened for tobacco use and received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling, pharmacotherapy, or both), if identified as a tobacco user
• M1311 – Anaphylaxis due to the vaccine on or before the date of the encounter
• M1312 – Patient not screened for tobacco use
• M1313 – Tobacco screening not performed or tobacco cessation intervention not provided during the measurement period or in the six months prior to the measurement period
• M1314 – Bmi not documented and no reason is given
• M1315 – Colorectal cancer screening results were not documented and reviewed; reason not otherwise specified
• M1316 – Current tobacco non-user
• M1318 – Patients who did not have documented contact with a csp for at least one of their screened positive hrsns within 60 days after screening or documentation that there was no contact with a csp
• M1319 – Patients who had documented contact with a csp for at least one of their screened positive hrsns within 60 days after screening
• M1320 – Patients who screened positive for at least 1 of the 5 hrsns
• M1321 – Patients who were not seen within 7 weeks following the date of injection for follow up or who did not have a documented iop or no plan of care documented if the iop was >25 mm hg
• M1322 – Patients seen within 7 weeks following the date of injection and are screened for elevated intraocular pressure (iop) with tonometry with documented iop =<25 mm hg for injected eye
• M1323 – Patients seen within 7 weeks following the date of injection and are screened for elevated intraocular pressure (iop) with tonometry with documented iop >25 mm hg and a plan of care was documented
• M1324 – Patients who had an intravitreal or periocular corticosteroid injection (e.g., triamcinolone, preservative-free triamcinolone, dexamethasone, dexamethasone intravitreal implant, or fluocinolone intravitreal implant)
• M1325 – Patients who were not seen for reasons documented by clinician for patient or medical reasons (e.g., inadequate time for follow-up, patients who received a prior intravitreal or periocular steroid injection within the last six (6) months and had a subsequent iop evaluation with iop <25mm hg within seven (7) weeks of treatment)